Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) can cure bone marrow failure in patients with Fanconi anemia (FA). Data on outcomes in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome (MDS), or acute leukemia have not been separately analyzed. PATIENT...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ayas, Mouhab, Saber, Wael, Davies, Stella M., Harris, Richard E., Hale, Gregory A., Socie, Gerard, LeRademacher, Jennifer, Thakar, Monica, Deeg, H. Joachim J., Al-Seraihy, Amal, Battiwalla, Minoo, Camitta, Bruce M., Olsson, Richard, Bajwa, Rajinder S., Bonfim, Carmem M., Pasquini, Ricardo, MacMillan, Margaret L., George, Biju, Copelan, Edward A., Wirk, Baldeep, Al Jefri, Abdullah, Fasth, Anders L., Guinan, Eva C., Horn, Biljana N., Lewis, Victor A., Slavin, Shimon, Stepensky, Polina, Bierings, Marc, Gale, Robert Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2013
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3635221/
https://ncbi.nlm.nih.gov/pubmed/23547077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.45.9719
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares